The field of cytokine biology has seen significant advancements, particularly concerning Interleukin-5 (IL-5) and its role in eosinophil-related disorders.

But in April, the Evans family learned that the NIH dismissed the grant application from Cincinnati Children’s to continue their research on eosinophilic disorders.

Eosinophilic Disorder Pipeline Insight - 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and ...

ABSTRACT: Eosinophilic gastrointestinal disorders (EGIDs) are a group of chronic inflammatory conditions characterized by eosinophil infiltration into the gastrointestinal (GI) tract, which includes ...

Advocacy organizations for eosinophilic disease, including the American Partnership for Eosinophilic Disorders (APFED) and the Campaign Urging Research for Eosinophilic Disease (CURED), have also ...

The Food and Drug Administration (FDA) has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA). EGPA is a rare autoimmune disease ...

There are many medications for eosinophilic esophagitis. Proton pump inhibitors, steroids, or a new drug, Dupixent, can all help you find relief.

Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss Syndrome, is a rare autoimmune disorder characterized by necrotizing vasculitis of small-to medium-sized blood ...

Eosinophilic esophagitis (EoE) is a condition that affects the esophagus — the tube that carries food and liquid from the mouth to the stomach. It happens when the body’s immune system ...